Turner Syndrome: Updating the Paradigm of Clinical Care
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
CONTEXT: Turner syndrome (TS), in which there is loss of all or part of one sex chromosome, occurs in one in 2500 live-born females and is associated with characteristic findings. Detailed healthcare checklists and screening guidelines are commonly used to detect known complications affecting individuals with TS. Even with the use of these guidelines, there remains an increased morbidity and mortality seen in TS as compared to the general population, leading to significant controversy on optimal management of several aspects of TS. EVIDENCE ACQUISITION AND SYNTHESIS: A PubMed search of articles from the past 15 yr identified available studies related to the diagnosis and management of common issues related to TS as well as important historical articles. This review summarizes studies through January 2012 and highlights recent developments. CONCLUSIONS: There remain many areas of uncertainty in the diagnosis and management of TS. Generalizations from experience in the care of other conditions in isolation (such as poor growth, follow-up of cardiac disease, or the treatment of ovarian failure) cannot be broadly applied when caring for individuals with TS. Specific differences include treatment of growth failure as early as possible; acquisition of adequate baseline cardiac studies, followed by serial magnetic resonance imaging, targeted to identify findings unique to TS that address the increased risk of aortic dissection; initiation of hormone replacement at the normal age of puberty, preferentially with transdermal estradiol; and detailed patient counseling to explain the long-term health risks commonly associated with this disorder. A revised paradigm of care using a standardized multidisciplinary evaluation, supplementing screening tests as advocated by expert opinion guidelines, can aid clinicians in interpreting the results of diagnostic testing in the context of TS. This approach optimizes medical care for women with TS and may reduce the increased morbidity and mortality currently seen in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005 · cited 4×
“Therefore current clinical practice guidelines do not yet recommend routine use of fluorescence in situ hybridization or PCR in 45,X patients with TS (2).”
BackgroundInfluentialMajor Vascular Anomalies in Turner Syndrome: Prevalence and Magnetic Resonance Angiographic Features
Ho, V. B., Bakalov, V. K., Cooley, M., Van, P. L., Hood, M. N., Burklow, T. R., & Bondy, C. A. (2004) · Circulation · doi:10.1161/01.cir.0000142290.35842.b0 · Cited by 316
Long-term safety of recombinant human growth hormone in children
Bell, J., Parker, K. L., Swinford, R. D., Hoffman, A. R., Maneatis, T., & Lippe, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0178 · Cited by 301 · cited 1×
“Scoliosis is reported more commonly with GH treatment in TS than in other conditions (64), so careful monitoring for scoliosis in addition to the above noted side effects is warranted.”
Background(2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2187 · Cited by 256 · cited 3×
“In a controlled, randomized study to adult height, patients with TS gained 7.3 cm over a mean of 5.7 yr of treatment with GH, even using doses slightly lower than those approved today in both Europe and the United States (32).”
InfluentialGrowth hormone plus childhood low-dose estrogen in Turner's syndrome
Ross, J. L., Quigley, C. A., Cao, D., Feuillan, P., Kowal, K., Chipman, J. J., & Cutler, G. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005669 · Cited by 212
Karnis, M. F., Zimon, A. E., Lalwani, S. I., Timmreck, L. S., Klipstein, S., & Reindollar, R. H. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00974-9 · Cited by 206
Prenatal and postnatal prevalence of Turner's syndrome: a registry study
Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J. (1996) · BMJ · doi:10.1136/bmj.312.7022.16 · Cited by 187 · cited 2×
“A review of the Danish cytogenetic registry showed that up to 30% of cases of TS diagnosed pre-natally showed a normal karyotype at delivery (11).”
BackgroundDelayed diagnoses of Turner's syndrome: proposed guidelines for change
Sävendahl, L., & Davenport, M. L. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.107390 · Cited by 180 · cited 1×
“Despite a general trend toward earlier age of diagnosis, retrospective analyses have shown that there is often a delay in the diagnosis of TS, averaging 5 yr after patients had fallen below the 5th percentile in height to time of diagnosis (24).”
BackgroundDavenport, M. L., Crowe, B. J., Travers, S. H., Rubin, K., Ross, J. L., Fechner, P. Y., Gunther, D. F., Liu, C., Geffner, M. E., Thrailkill, K., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2874 · Cited by 147
Ostberg, J. E., Brookes, J. A. S., McCarthy, C., Halcox, J., & Conway, G. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1090 · Cited by 146
Cited by
Turner syndrome in girls presenting with coarctation of the aorta
Eckhauser, A., South, S. T., Meyers, L., Bleyl, S. B., & Botto, L. D. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.08.002 · Cited by 50
Fiot, E., Zénaty, D., Boizeau, P., Haignere, J., Dos Santos, S., Léger, J., _, _., _, _., Carel, J. C., Cabrol, S., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0878 · Cited by 48
Analysis of PTPN 22, ZFAT and MYO 9B polymorphisms in Turner Syndrome and risk of autoimmune disease
Villanueva‐Ortega, E., Ahedo, B., Fonseca‐Sánchez, M. A., Pérez‐Durán, J., Garibay‐Nieto, N., Macías‐Galavíz, M. T., Trujillo‐Cabrera, Y., García‐Latorre, E., & Queipo, G. (2017) · International Journal of Immunogenetics · doi:10.1111/iji.12323 · Cited by 12
“Turner syndrome (TS) is one of the most common sexual chromosome abnormalities, affecting 1/2500 live female births (Pinsker, 2012).”
BackgroundMohamed, S., Roche, E. F., & Hoey, H. M. C. V. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0287 · Cited by 8
Detection of Turner Syndrome by Quantitative PCR of SHOX and VAMP7 Genes
Ibarra-Ramírez, M., Zamudio-Osuna, M. J., Campos-Acevedo, L. D., Gallardo-Blanco, H. L., Cerda-Flores, R. M., Rodríguez-Sánchez, I. P., & Martínez-de-Villarreal, L. E. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0236 · Cited by 8
Metadata
- Authors
- Pinsker, J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-06-01
- Volume
- 97
- Issue
- 6
- Pages
- E994-E1003
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2092019905
- Cited by
- 125
- References
- 24
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Turner Syndrome: Updating the Paradigm of Clinical Care. https://app.cochat.ai/papers/10.1210/jc.2012-1245
- The paper
- Pinsker, J. E. (2012). Turner Syndrome: Updating the Paradigm of Clinical Care. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-1245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.